Combination doxorubicin and interferon-α therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I. | Asian Pac J Cancer Prev;15(22): 9667-72, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Combination doxorubicin and interferon-α therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I.

Wang, Wen-Jia; Qin, Si-Hao; Zhang, Ji-Wei; Jiang, Yue-Yao; Zhang, Jin-Nan; Zhao, Lei.

Affiliation

Wang WJ; Institute of Pharmacy, Jilin University, Changchun, Jilin, China E-mail : zjghospital@sina.com.

Asian Pac J Cancer Prev ; 15(22): 9667-72, 2014.

Article in En | MEDLINE | ID: mdl-25520086

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Histocompatibility Antigens Class I / Doxorubicin / Interferon-alpha / NK Cell Lectin-Like Receptor Subfamily K Limits: Animals Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Histocompatibility Antigens Class I / Doxorubicin / Interferon-alpha / NK Cell Lectin-Like Receptor Subfamily K Limits: Animals Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: